Filed: 2/14/2025ACC: 0001085146-25-001519
📋 What this filing means
FIRST TURN MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 36 equity positions with a total reported market value of $558.33M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
36
Positions
$558.33M
Total AUM (reported)
17.59M
Total Shares
Allocation by class
COM$405.95M72.7%
SPONSORED ADR$38.58M6.9%
COM PAR $.01$30.86M5.5%
SPONSORED ADS$29.81M5.3%
COM NEW$21.79M3.9%
CL A$19.66M3.5%
COMMON STOCK$11.68M2.1%
Portfolio Concentration
Top 3$87.52M15.7%
4–10$162.66M29.1%
11–25$217.52M39.0%
Rest$90.63M16.2%
Top 3 weight
15.7%
Top 10 weight
44.8%
Voting Authority Distribution
Total shares with voting rights: 17.59M
Sole
Full voting authority
17.59M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole36
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings36
Rows:
INSMED INC
SOLEShares446.98K
TypeSH
Market value$30.86M
5.53%
Sole
446.98K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares641.90K
TypeSH
Market value$29.81M
5.34%
Sole
641.90K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares684.99K
TypeSH
Market value$26.85M
4.81%
Sole
684.99K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares43.08K
TypeSH
Market value$26.49M
4.75%
Sole
43.08K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares294.41K
TypeSH
Market value$24.59M
4.40%
Sole
294.41K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares309.52K
TypeSH
Market value$24.23M
4.34%
Sole
309.52K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares453.38K
TypeSH
Market value$23.18M
4.15%
Sole
453.38K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares276.90K
TypeSH
Market value$22.67M
4.06%
Sole
276.90K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares506.91K
TypeSH
Market value$20.96M
3.75%
Sole
506.91K
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
SOLEShares383.60K
TypeSH
Market value$20.54M
3.68%
Sole
383.60K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares464.81K
TypeSH
Market value$19.66M
3.52%
Sole
464.81K
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
SOLEShares35.03K
TypeSH
Market value$18.29M
3.27%
Sole
35.03K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares403.92K
TypeSH
Market value$17.67M
3.16%
Sole
403.92K
Shared
0.00
None
0.00
EXACT SCIENCES CORP
SOLEShares309.89K
TypeSH
Market value$17.41M
3.12%
Sole
309.89K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares192.15K
TypeSH
Market value$16.26M
2.91%
Sole
192.15K
Shared
0.00
None
0.00
NATERA INC
SOLEShares99.16K
TypeSH
Market value$15.70M
2.81%
Sole
99.16K
Shared
0.00
None
0.00
GLAUKOS CORP
SOLEShares96.10K
TypeSH
Market value$14.41M
2.58%
Sole
96.10K
Shared
0.00
None
0.00
GERON CORP
SOLEShares3.89M
TypeSH
Market value$13.78M
2.47%
Sole
3.89M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares452.29K
TypeSH
Market value$12.41M
2.22%
Sole
452.29K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares87.80K
TypeSH
Market value$12.09M
2.17%
Sole
87.80K
Shared
0.00
None
0.00
HEALTHEQUITY INC
SOLEShares125.87K
TypeSH
Market value$12.08M
2.16%
Sole
125.87K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares535.09K
TypeSH
Market value$12.04M
2.16%
Sole
535.09K
Shared
0.00
None
0.00
DAY ONE BIOPHARMACEUTICALS I
SOLEShares947.88K
TypeSH
Market value$12.01M
2.15%
Sole
947.88K
Shared
0.00
None
0.00
MERUS N V
SOLEShares285.16K
TypeSH
Market value$11.99M
2.15%
Sole
285.16K
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares684.23K
TypeSH
Market value$11.73M
2.10%
Sole
684.23K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
INSMED INCSOLE | COM PAR $.01 | 446.98K | SH | $30.86M 5.53% | 446.98K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 641.90K | SH | $29.81M 5.34% | 641.90K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 684.99K | SH | $26.85M 4.81% | 684.99K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 43.08K | SH | $26.49M 4.75% | 43.08K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 294.41K | SH | $24.59M 4.40% | 294.41K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 309.52K | SH | $24.23M 4.34% | 309.52K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 453.38K | SH | $23.18M 4.15% | 453.38K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 276.90K | SH | $22.67M 4.06% | 276.90K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 506.91K | SH | $20.96M 3.75% | 506.91K | 0.00 | 0.00 |
JANUX THERAPEUTICS INCSOLE | COM | 383.60K | SH | $20.54M 3.68% | 383.60K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 464.81K | SH | $19.66M 3.52% | 464.81K | 0.00 | 0.00 |
INTUITIVE SURGICAL INCSOLE | COM NEW | 35.03K | SH | $18.29M 3.27% | 35.03K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 403.92K | SH | $17.67M 3.16% | 403.92K | 0.00 | 0.00 |
EXACT SCIENCES CORPSOLE | COM | 309.89K | SH | $17.41M 3.12% | 309.89K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 192.15K | SH | $16.26M 2.91% | 192.15K | 0.00 | 0.00 |
NATERA INCSOLE | COM | 99.16K | SH | $15.70M 2.81% | 99.16K | 0.00 | 0.00 |
GLAUKOS CORPSOLE | COM | 96.10K | SH | $14.41M 2.58% | 96.10K | 0.00 | 0.00 |
GERON CORPSOLE | COM | 3.89M | SH | $13.78M 2.47% | 3.89M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 452.29K | SH | $12.41M 2.22% | 452.29K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 87.80K | SH | $12.09M 2.17% | 87.80K | 0.00 | 0.00 |
HEALTHEQUITY INCSOLE | COM | 125.87K | SH | $12.08M 2.16% | 125.87K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 535.09K | SH | $12.04M 2.16% | 535.09K | 0.00 | 0.00 |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 947.88K | SH | $12.01M 2.15% | 947.88K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 285.16K | SH | $11.99M 2.15% | 285.16K | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 684.23K | SH | $11.73M 2.10% | 684.23K | 0.00 | 0.00 |
Page 1 of 2